PARSIPPANY, N.J., Feb. 10, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) ("Interpace" or the "Company"),a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, today announced that its President & Chief Executive Officer, Jack E. Stover, will deliver a corporate
Details for this presentation are as follows:
A live webcast of Interpace Diagnostics' presentation may be accessed by logging onto the internet at http://www.veracast.com/webcasts/bio/ceoinvestor2017/69132493167.cfm. A replay will be archived and accessible for 90 days at the same website.
About Interpace Diagnostics Group
Interpace is a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management. The Company currently has three commercialized molecular tests: PancraGEN®, for the evaluation of pancreatic cysts and assessment of risk of concomitant or subsequent cancer; ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay; and ThyraMIR®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. Interpace's mission is to provide personalized medicine through molecular diagnostics and innovation to advance patient care based on rigorous science. For more information, please visit Interpace Diagnostics' website at www.interpacediagnostics.com.
CONTACTS:Victor RobertsRedChip Companies407.644.4256, ext. email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/interpace-diagnostics-to-present-at-2017-bio-ceo--investor-conference-300405706.html
SOURCE Interpace Diagnostics Group, Inc.
Subscribe to our Free Newsletters!
Increasing weight and obesity are some of the most common health problems today. A smart weight ...
Adrenalectomy is a surgery that involves removing either one or both the adrenal glands.
Craniosynostosis is a condition where the bones of the skull are fused together prematurely ...View All